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a b s t r a c t
Studies have suggested that the glycosphingolipid globoside (Gb4Cer) is a receptor for human parvovirus
B19. Virus-like particles bind to Gb4Cer on thin-layer chromatograms, but a direct interaction between
the virus and lipid membrane-associated Gb4Cer has been debated. Here, we characterized the binding
of parvovirus B19 VP1/VP2 virus-like particles to glycosphingolipids (i) on thin-layer chromatograms
(TLCs) and (ii) incorporated into supported lipid bilayers (SLBs) acting as cell-membrane mimics. The
binding speciﬁcities of parvovirus B19 determined in the two systems were in good agreement; the VLP
recognized both Gb4Cer and the Forssman glycosphingolipid on TLCs and in SLBs compatible with the
role of Gb4Cer as a receptor for this virus.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The majority of human parvovirus B19 (B19V) infections occur
during childhood and are manifested as a mild self-limited rash
called erythema infectiosum or the ﬁfth disease (Servant-Delmas
et al., 2010; Servey et al., 2007). However, when infecting indivi-
duals with immune or hematologic disorders, B19V can cause
more severe symptoms such as acute and persistent anemia and
arthropathies (Florea et al., 2007). Furthermore, infections during
pregnancy may lead to hydrops fetalis, and fetal death (Yaegashi et
al., 1998). The virus has a tropism for erythroid progenitor cells
and the infection leads to cytotoxicity and interruption of ery-
throcyte production (Servant-Delmas et al., 2010).
B19V belongs to the Erythrovirus genus of the Parvoviridae
family and is a non-enveloped single stranded DNA virus (Servant-
Delmas et al., 2010). The virus capsid has a diameter of approxi-
mately 280 Å and is formed from two proteins, VP1 and VP2. The
capsid has an icosahedral symmetry and consists of 60 structural
subunits, of which in average 57 are VP2 and 3 are VP1. The two
proteins differ through an additional N-terminal sequence of 227
amino acids on VP1.
For the past 20 years, the glycosphingolipid (GSL) globoside/
globotetraosylceramide (Gb4Cer) has been considered a receptor
for B19V. This stems from observations showing that the virus
binds to Gb4Cer on thin-layer chromatogram (TLC) plates and that
the globoside carbohydrate structure (Gb4) is essential for the
cellular entry of the virus (Brown et al., 1994, 1993). Speciﬁcally,
anti-Gb4 antibodies were shown to inhibit, B19V in vitro infection
of bone marrow mononuclear cells (Brown et al., 1993). Moreover,
puriﬁed Gb4Cer was demonstrated to block binding of the virus
to erythroid cells and affect the infectivity of the virus in a
hematopoietic colony assay (Brown et al., 1993). The signiﬁcance
of Gb4 is also supported by host genetic data: expression of Gb4 in
humans is determined by the blood group P system, in which
individuals of the rare blood group variant “p” lack expression of
Gb4, a condition that was shown to be associated with resistance
to B19V infection (Brown et al., 1994). More recent studies support
a role for Gb4Cer as receptor for B19V (Bon̈sch et al., 2010; Leisi
et al., 2013). However, these studies also demonstrated that the
interaction between the virus and Gb4 induced structural changes
in the viral capsid. These changes allowed the unique VP1 region
to interact with a co-receptor, which was suggested to be required
for ﬁrm attachment and internalization of the virus.
The role of Gb4Cer as B19V receptor has been questioned by
Kaufmann et al. (2005), who reported that the virus does not
bind to Gb4Cer in phospholipid membranes. This observation
would imply that Gb4Cer, although binding to B19V in the
chromatogram-binding assay, might not act as a bona ﬁde receptor
to B19V owing to the suggested lack of binding to lipid membrane
associated Gb4Cer.
The question whether Gb4Cer constitutes a B19V receptor is
not trivial. At present no functioning chemotherapy to B19V or
other parvoviruses is available. The existence of a small oligosac-
charide epitope as a B19V ligand opens perspectives for identifying
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the binding paratope at the viral capsid by molecular modeling, as
previously described by us for noroviruses (Koppisetty et al., 2010).
This may pave the way for development of tailor-made attachment
inhibitors for instance based on multivalent glycan analogs
(Bernardi et al., 2012), and would beneﬁt from knowledge regard-
ing the nature of the presentation and viral binding characteristics
of Gb4Cer presented at the plasma membrane and required for
virus infection.
As a complementary and versatile tool to study interactions
between viruses and GSLs incorporated into supported lipid
bilayers, we have previously introduced quartz crystal microba-
lance with dissipation monitoring (QCM-D) (Bally et al., 2012;
Rydell et al., 2009). In this method, a planar silica surface acts as a
solid support for the phospholipid bilayer, which is deposited on
the sensor surface by spontaneous vesicle adsorption and fusion
into a supported lipid bilayer. While providing unique signatures
for a successful bilayer formation, the QCM-D technique is a
powerful method to study the kinetics of supported lipid bilayer
formation and subsequent interactions with membrane binding
entities (Cho et al., 2010). The QCM-D technique is based on an
oscillating piezoelectric quartz crystal and relates changes in its
resonance frequency to the sensor-bound mass. Additionally, the
measurements of changes in the dampening of the sensor's
oscillation provide information about the viscoelastic and struc-
tural properties of the sensor-bound molecules. Thereby, adsorbed
lipid vesicles, which induce high damping, are distinguishable
from planar supported membranes, which induce very little
damping.
We were intrigued by the opposing results regarding B19V-
Gb4Cer interactions, which may originate from differences with
respect to how Gb4Cer is presented to the virus. We were also
well-aware of a number of studies demonstrating distinctive GSL-
protein interactions depending on a number of GSL-membrane
physico-chemical parameters (membrane ﬂuidity, GSL mobility,
and GSL conformation) (Bally et al., 2012; Evans and Roger
MacKenzie, 1999; Lingwood, 2011, 1996; Nyholm and Pascher,
1993). Therefore, in this work, we assayed the interactions
between B19V and membrane-associated Gb4Cer using QCM-D.
In this way, we have characterized the interaction of a B19V VLP
with GSLs incorporated into well-deﬁned supported lipid bilayers.
Binding speciﬁcity towards different GSLs was further veriﬁed
using a chromatogram-binding assay and the binding pattern was
in essence congruent with that of earlier studies. These data are
compatible with the notion that B19V also recognizes membrane-
associated Gb4Cer, reconstituting Gb4Cer as a conceivable receptor
for this virus.
Results
The VLP recognizes Gb4Cer and the Forssman GSL on thin-layer
chromatograms
To verify and compare the binding speciﬁcity of the B19V VP1/
VP2 VLP to earlier studies, GSLs were chromatographed on thin-
layer chromatograms, which were plasticized and incubated with
B19V VLPs as previously described (Rydell et al., 2009). Bound
VLPs were detected using antibodies and alkaline phosphatase
(ALP) staining. Gb4Cer, Forssman (Gb5Cer) and neolactotetraosyl-
ceramide (nLc4Cer) GSLs were assayed for binding since they have
been reported to bind B19V in similar assays in previous studies
(Table 1, Fig. 1A) (Brown et al., 1993; Cooling et al., 1995).
Globotriaosylceramide (Gb3Cer) was included as the negative
control (Brown et al., 1993) and the VLP binding was assayed at
two different concentrations (20 μg/mL and 2 μg/mL). Binding to
Gb4Cer and Gb5Cer was observed for both concentrations (Fig. 1B
and C). A very faint band corresponding to nLc4Cer binding was
observed at 20 μg/mL, but not at 2 μg/mL. No binding to Gb3Cer
was detected in any of the conditions. To exclude the possibility
that any of the used antibodies cross-reacted with the GSLs, a
control plate was incubated with the antibodies, but without the
VLP. No binding was observed in this case (Fig. 1D).
The VLP recognizes bilayers containing Gb4Cer and Gb5Cer
Bilayer formation
To form supported lipid bilayers, POPC vesicles containing GSLs
were injected into the QCM-D reaction chamber. A typical bilayer
formation process is shown in Fig. 2A. At ﬁrst, the vesicles
adsorbed intact to the SiO2-coated QCM-crystal which resulted
in a decrease in resonance frequency, f (black curve), associated
with the increase in mass at the sensing interface. At the same
Table 1
Names, abbreviations and structures of the glycosphingolipids investigated in this study.
Name Abbreviation Structure
Globotriaosylceramide Gb3Cer α4 β4
Globotetraosylceramide/Globoside Gb4Cer β3 α4 β4
Globopentaosylceramide/Forssman Gb5Cer α3 β3 α4 β4
Neolactotetraosylceramide nLc4Cer β4 β3 β4
Galactose; Glucose; N-acetylgalactoseamine N-acetylglucoseamine.
Fig. 1. The B19V VLP recognizes globoside (Gb4Cer) and Forssman (Gb5Cer) glycosphingolipids on thin-layer chromatograms. Glycosphingolipids were chromatographed on
thin-layer plates which were either stained for glycosphingolipids using anisaldehyde (A) or plasticized and incubated with VLP 20 μg/mL (B), 2 μg/mL (C) or buffer without
VLP (D). Attached VLPs were detected using antibodies and alkaline phosphatase staining. The VLP recognized Gb4Cer and Gb5Cer. A weak band corresponding to nLc4Cer
was observed at 20 μg/mL.
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time, the energy dissipation, D (gray curve) increased, in agree-
ment with the formation of a soft and dissipating layer of intact
water-ﬁlled vesicles. When a critical vesicle coverage was reached,
the vesicles ruptured and released the water, resulting in an
increase in the f signal (decrease in bound mass at the sensor
surface). The so-formed supported lipid bilayer is a rather rigid
structure which induces little dampening of the crystal oscillation.
Peaks in f and D were therefore followed by signal stabilization at
ca 30 Hz and 0.25106, respectively. For all bilayers, the
monitored signals were in agreement with a typical bilayer
formation process suggesting that high-quality bilayers with a
low number of intact vesicles were formed (Cho et al., 2010).
Binding of parvovirus VLP
VLP binding was assayed at 13 mg/mL in the presence of BSA to
avoid VLP aggregation. When a stable baseline was achieved, VLPs
were injected into the reaction chamber at a ﬂow rate of 50 μL/
min. To reduce VLP consumption, the ﬂow was interrupted 2.5 min
after the VLPs had reached the ﬂow cell. Binding was further
monitored under stagnant conditions until the signal stabilized.
A representative binding curve for Gb4Cer is shown in Fig. 2B,
upper panel. The binding process could be followed in real time
and is associated to a decrease in f (black curve) and an increase in
D (gray curve). The total change in f was 12.871.8 Hz after around
2 h. Half of the response was achieved after around 20 min. Less
than 30% of the bound VLPs were released when the chamber was
washed under constant buffer ﬂow until the signal was
stable (around 40 min). VLP adsorption to Gb5Cer bilayers gave
similar responses with a marginally lower signal than the Gb4Cer
bilayers (Fig. 2C). The signal from the nLc4Cer bilayer was only 10%
of the Gb4Cer signal (Fig. 2B, lower panel and Fig. 2C), and
comparable to the signal on POPC bilayers without GSLs.
To further characterize VLP binding to Gb4Cer, bilayers with
different densities of the GSL were assayed (Fig. 2D). VLP binding
depended linearly on Gb4Cer concentration between 2.5% and 10%
both at a VLP concentration of 13 μg/mL and 26 μg/mL. Extrapola-
tion of a linear regression to the concentration-dependent
response does not cross the intercept, suggesting that a threshold
density of Gb4Cer is required for VLP binding.
Discussion
In the present study we report, for the ﬁrst time, a direct
interaction between B19V VLPs and GSLs embedded in supported
lipid bilayers, a lipid structure known to mimic the lipid bilayer
structure of natural cell membranes. Our work demonstrates
therefore that parvovirus VLPs can, under these experimental
conditions, bind to membrane-associated Gb4Cer. This ﬁnding is
in contrast to a previous study, which although seemingly well-
conducted, failed to demonstrate direct binding between B19V and
membrane associated Gb4Cer (Kaufmann et al., 2005). Considering
this discrepancy, it is important to recall that the binding of non-
enveloped viruses to GSLs in lipid membranes is mediated by the
establishment of multiple weak GSL-capsid bonds leading to a
successive increase in avidity (Bally et al., 2011; Mammen et al.,
2010). For such multivalent interactions, there is a growing body of
evidence that the overall physico-chemical properties of the lipid
environment can have a substantial inﬂuence on the binding
strength. Factors such as membrane ﬂuidity, membrane curvature,
ligand mobility or ligand conformation are indeed believed to play
a key role in modulating protein–carbohydate interaction (Bally et
al., 2012; Evans and Roger MacKenzie, 1999; Lingwood, 2011,
1996; Nyholm and Pascher, 1993). Kaufmann et al. assayed binding
of ﬂuorescent vesicles containing GSLs to immobilized VLPs as
well as VLP binding to membrane-associated GSLs immobilized on
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Fig. 2. The B19 VLP recognizes globoside (Gb4Cer) and Forssman (Gb5Cer)
glycosphingolipids in supported lipid bilayers. (A) Plot of resonance frequency
(f, black curve) and dissipation energy (D, gray curve) shift versus time illustrating
the bilayer formation process. Vesicles were injected at t¼0 min and started to
attach to the sensor. A characteristic peak in f and D was observed at around
6 min, whereafter vesicles collapsed into a bilayer with f¼30 Hz and
Do0.5106. (B) Changes of f and D over time during binding of B19V VLP to
bilayers containing 10% by weight of Gb4Cer (upper panel) or nLc4Cer (lower
panel). VLP was injected at t¼0 min. 2.5 min after the VLP had entered the ﬂow
cell, the pump was turned off and the binding kinetics monitored in stagnant
chamber. Washing in ﬂow mode was started at t¼160 min. (C). Normalized f
shifts of B19V VLP binding to bilayers containing 10% of Gb4Cer, Gb5Cer or
nLc4Cer or without glycosphingolipids (-). The bars represents the mean of two
independent experiments and the error bars the standard deviation. (D) The
binding of B19 VLP to bilayers containing Gb4Cer is dependent on the concentra-
tion of the glycosphingolipid. Normalized f shifts for VLP binding to bilayers
containing different densities of Gb4Cer. The line is a linear regression of all the
data points between 2.5% and 10% Gb4Cer extrapolated to Y¼0. The pump was
turned off 2.5 min after VLP had reached the ﬂow cell and the binding kinetics
were monitored in stagnant conditions. The binding was linearly dependent on
Gb4Cer concentration between 2.5% and 10% Gb4Cer.
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alkyl-modiﬁed dextran sensor chips. The latter surfaces have, in
most studies, been found to immobilize intact vesicles (Besenicar et
al., 2006; Cooper, 2004; Erb et al., 2000) and planar bilayer
formation remains uncertain. Rather, lipid vesicles are likely to be
exposed, thus presenting a structure quite different from a planar
bilayer. In our study, we used a supported lipid bilayer and its
successful formation was veriﬁed by QCM-D. Furthermore, the lipid
assembly was deposited directly on the silicon dioxide surface
without any molecular anchors, which may affect the bilayer's
ﬂuidity (Cho et al., 2010). A major difference between Kaufmann's
study and ours is therefore related to the nature of the lipid assembly
used, where our approach results in the formation of a planar lipid
bilayer, and its successful formation was veriﬁed by direct measure-
ments of the lipid-associated sensor's oscillation. Thus, differences in
the nature of the GSL environment, which may also be affected by
the ceramide composition of the GSL, may very well explain the
discrepancy between our study and Kaufmann et al.
An alternative reason for the discrepancy might be the VLPs
themselves. While we used VP1/VP2 VLPs, Kaufmann et al. used
VLPs assembled from VP2 only, for most of their experiments.
Recent studies have highlighted a role of the VP1 unique region in
cellular attachment of B19V (Bon̈sch et al., 2010; Leisi et al., 2013).
These studies suggested that the VP1 unique region becomes
exposed upon VLP binding to Gb4, and subsequently binds to a
co-receptor. However, it cannot be excluded that the stronger
attachment to cells observed after exposure of this region is
mediated by a strengthening of the interaction with Gb4.
The strong and speciﬁc binding to membrane associated
Gb4Cer and Gb5Cer observed in the QCM-D experiments
(Fig. 2C) was in good agreement with the chromatogram-binding
assay experiments in the present study (Fig. 1) as well as in
previous reports (Brown et al., 1993; Cooling et al., 1995). One
difference between ours and previously published data is regard-
ing nLc4Cer, for which we only observed a very faint signal at
20 μg VLP/mL, but not at 2 μg/mL in the chromatogram-binding
assay or in the QCM-D assay. This weak interaction indicates that
the binding speciﬁcity of our VLP differs from the one used by
Cooling et al., since they reported strong binding to nLc4 (Cooling
et al., 1995).
The experiment with bilayers using different concentrations of
Gb4Cer indicated that a threshold density of GSL is required for a
stable binding to form, which is characteristic of multivalent
interactions (Dam and Brewer, 2010). We have previously
observed a similar threshold concentration in QCM-D studies of
norovirus VLP attachment to POPC bilayers containing H type
1 GSL (Rydell et al., 2009).
Although the two GSLs recognized by the B19V VLP in the
present study are structurally very similar, differing only in the
terminal α3-linked GalNAc found on Gb5Cer (Table 1) there is a
prominent difference in their abundance at human cell surfaces.
Thus, most humans lack expression of Gb5 because of inactivating
mutations in the GalNAc transferase (Gb5 synthase) converting
Gb4 to Gb5 (Yamamoto et al., 2012). However, a small fraction of
the population has recently been demonstrated to have a func-
tional Gb5 synthase (Svensson et al., 2013) implying that Gb5Cer
cannot be excluded as an additional receptor structure for B19V in
humans. Indeed in 2012, FORS, was ofﬁcially recognized by the
International Society of Blood Transfusion as a new blood group
system. It appears that the β3-linked GalNAc shared by Gb4Cer
and Gb5Cer is crucial for the binding, as Gb3Cer being the
precursor substrate and lacking this monosaccharide does not
bind the VLP.
Binding of B19V to Gb4Cer reported by us and others (Brown et
al., 1993; Cooling et al., 1995) indicates that the carbohydrate
epitope Gb4 is a potential receptor for B19V. The possibility that
the receptor is a glycoprotein carrying the Gb4 epitope appears
rather unlikely since the Gb4 glycan epitope, although abundant in
cell surface GSLs, has not yet been found in any human glycopro-
tein (Yang et al., 1994). The lack of binding to membrane asso-
ciated Gb4Cer in the previous study led therefore to the suggestion
that additional receptors are required for B19V cell attachment
(Kaufmann et al., 2005), a conclusion cited in several subsequent
publications (Bon̈sch et al., 2010, 2008; Gallinella, 2013; Leisi et al.,
2013). Our observation that the Gb4Cer alone can promote viral
attachment to membranes further supports the previous notion
that a Gb4 epitope is indeed a major receptor candidate for B19V
(Brown et al., 1994, 1993) and, moreover, our ﬁnding provides an
important link between the TLC binding data and cellular infection
data reported earlier (Brown et al., 1994, 1993). Thus, in contrast to
the suggestion by Kaufmann et al. (2005) our data support the notion
that the mere enrichment of B19V at the surface of a permissive cell
may take place without any involvement of other cell surface
molecules. However, the present study does not exclude that addi-
tional receptors are required for the entry of the virus (Weigel-Kelley
et al., 2003) or that additional attachment receptors may exist
(Munakata et al., 2005). Recent studies have dealt with the char-
acterization of the GSL receptor function, demonstrating that for
Shiga toxin and Simian virus 40 GSLs are responsible for the initiation
of the entry process (Ewers et al., 2010; Romer et al., 2007). The
multivalent binding of viruses and toxins to GSLs was shown to lead
to the formation of tubular membrane invaginations (Ewers et al.,
2010; Romer et al., 2007; Rydell et al., 2013). By this mechanism the
pathogens/pathogenic factors can trigger their own uptake indepen-
dently of host cell coat proteins such as clathrin or caveolin (Eierhoff
et al., 2012; Ewers and Helenius, 2011; Sens et al., 2008).
Materials and methods
Glycosphingolipids
The glycosphingolipids used in this study were puriﬁed by
repeated silicic acid column chromatography of native non-
acetylated and acetylated derivatives. Gb4Cer was puriﬁed from
human erythrocytes and Gb5Cer was from a dog's small intestine
(Nilsson et al., 2009a). Gb3Cer was puriﬁed from meconium from a
single Lea-bþ individual (Karlsson and Larson, 1981). nLc4Cer was
prepared by treating sialyl-paragloboside (Siaα6Galβ4GlcNAcβ3-
Galβ4Glcβ1Cer), originating from human erythrocytes, with 0.1 M
formic acid at 80 1C for 30 min (Nilsson et al., 2009b). A white
precipitate formed and after centrifugation the pellet was dissolved
in chloroform:methanol:water (40:40:12 by volume), and was
further puriﬁed on a silica gel column using 40:40:12 (yield 72%).
To conﬁrm the purity and identity, the GSLs were all analyzed by 1H
NMR spectroscopy, using a 600 MHz NMR spectrometer (Varian
Unity) at 303 K, and compared to previous characterizations by 1H
NMR and mass spectrometric analyses of permethylated and
permethylated-reduced derivatives (Karlsson and Larson, 1981;
Nilsson et al., 2009a). The anomeric shifts of nLc4Cer was 4.65 ppm
(GlcNAcβ3), 4.25 ppm (inner Galβ4), 4.21 ppm (terminal Galβ4), and
4.17 ppm (Glcβ1) in DMSO-d6 containing 2% D2O, which is in
accordance with the literature (Clausen et al., 1986).
VLP and antibodies
The B19V VP1/VP2 VLP (48100) was obtained from Diarect AG,
Freiburg, Germany. The VLP was formed by recombinantly expres-
sing VP1 and VP2 in Sf9 insect cells. VLP formation was conﬁrmed
by sedimentation behavior during puriﬁcation via density gradient
centrifugation and negative staining electron microscopy. The
stoichiometry of VP1 and VP2 (approximately 1:20) was veriﬁed
by Western blot. The VLP was shipped on dry ice. Upon arrival it
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was aliquoted, snap frozen in liquid nitrogen and stored at 80 1C.
The monoclonal anti-B19V antibody was obtained from Millipore
(Billerica, MA) and the ALP conjugated secondary anti-mouse
antibody was obtained from Sigma (St Louis, MO).
Chromatogram binding assay
The chromatogram-binding assay was essentially performed as
described previously (Hansson et al., 1984; Rydell et al., 2009).
In brief, GSLs were chromatographed on alumina-backed silica gel
60 HPTLC plates in chloroform:methanol:water (60:35:8 by
volume). After drying, the plate was cut into parts, which were
either chemically stained by spraying with anisaldehyde or plas-
ticized with polyisobutylmethacrylate (P28). Plasticized plates
were blocked with PBS containing 0.05% Tween-20 and 0.5% BSA
before being incubated with VLP. A monoclonal antibody towards
B19V and a secondary alkaline phosphatase conjugated antibody
was used for detection of bound VLPs. Immunostaining was
developed with Sigma Fast BCIP/NBT.
Vesicle preparation
Lipid vesicles were prepared by mixing appropriate amounts of
GSLs and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphorylcholine
(POPC, Avanti Polar Lipids, Alabaster, ALSA) dissolved in chloro-
form:methanol (2:1 by volume). The solvent was evaporated under
N2 and further incubated in a vacuum desiccator for at least 2 h. The
lipid ﬁlm was hydrated in PBS to a ﬁnal concentration of 0.3 mg/mL
and the solution was mixed vigorously for 5 min. The mixture was
then pressed at least 13 times through a 30 nm polycarbonate
membrane (Whatman, Maidstone, UK) using an Avanti MiniExtruder.
The so-obtained vesicles were stored at 4 1C until use.
QCM-D
A Q-Sense E4 instrument (Q-Sense AB, Västra Frölunda, Sweden)
with four parallel sample chambers was used for the QCM-D
measurements. SiO2-coated quartz crystals (QSX 303) were obtained
from Q-Sense AB. The sensor crystals were cleaned by overnight
incubation in 10 mM SDS. After being rinsed in Milli Q water and
dried under a stream of N2, the crystals were UV–ozone treated
(atmospheric, homebuilt UV chamber) for 40 min. After mounting
the crystals in the QCM-D chamber, the baseline was achieved in PBS.
Lipid vesicles were injected at a concentration of 0.1 mg/mL (600 mL,
50 mL/min). When a stable bilayer was achieved, the buffer was
changed to PBS with a glycerol concentration matching the concen-
tration in the VLP solution used (PBS/Glyc). As the density and
viscosity of the buffer affects the QCM-D measurement, the buffer
change resulted in a change in f and D of around 2 Hz and
1.25106, respectively. Thereafter PBS/Glyc with 0.5% BSA was
injected, resulting in a change in f and D of around of 3 Hz and
1.5106, respectively. These changes were quickly reversed when
the buffer was changed back to PBS after the experiment.
The VLP stock solution (0.38 mg/mL) containing 20% Glycerol
was diluted in PBS/BSA (0.5% BSA) and injected at 50 mL/min.
2.5 min after the VLP had entered the ﬂow cells the pump was
turned off and the binding monitored in stationary conditions.
Acknowledgments
We are grateful to Prof. Göran Larson, Department of Clinical
Chemistry and Transfusion Medicine, University of Gothenburg
and Prof. Fredrik Höök, Department of Applied Physics, Chalmers
University of Technology for fruitful discussions and comments on
the manuscript. Göran Larson also kindly provided GSLs. We
acknowledge the Swedish NMR centre at the University of
Gothenburg for NMR spectrometer time. The study was supported
by the Swedish Research Council (623-2012-6989, 621-2012-5024
and 8266) and VINNOVA.
References
Bally, M., Gunnarsson, A., Svensson, L., Larson, G., Zhdanov, V., Hoök̈, F., 2011.
Interaction of single viruslike particles with vesicles containing glycosphingo-
lipids. Phys. Rev. Lett. 107, 188103.
Bally, M., Rydell, G.E., Zahn, R., Nasir, W., Eggeling, C., Breimer, M.E., Svensson, L.,
Hoök̈, F., Larson, G., 2012. Norovirus GII.4 virus-like particles recognize
galactosylceramides in domains of planar supported lipid bilayers. Angew.
Chem. Int. Ed. 51, 12020–12024.
Bernardi, A., Jiménez-Barbero, J., Casnati, A., De Castro, C., Darbre, T., Fieschi, F.,
Finne, J., Funken, H., Jaeger, K.-E., Lahmann, M., Lindhorst, T.K., Marradi, M.,
Messner, P., Molinaro, A., Murphy, P.V., Nativi, C., Oscarson, S., Penadés, S., Peri,
F., Pieters, R.J., Renaudet, O., Reymond, J.-L., Richichi, B., Rojo, J., Sansone, F.,
Schäffer, C., Turnbull, W.B., Velasco-Torrijos, T., Vidal, S., Vincent, S., Wennekes,
T., Zuilhof, H., Imberty, A., 2012. Multivalent glycoconjugates as anti-pathogenic
agents. Chem. Soc. Rev. 42, 4709–4727.
Besenicar, M., Macek, P., Lakey, J.H., Anderluh, G., 2006. Surface plasmon resonance
in protein-membrane interactions. Chem. Phys. Lipids 141, 169–178.
Brown, K.E., Anderson, S.M., Young, N.S., 1993. Erythrocyte P antigen: cellular
receptor for B19 parvovirus. Science 262, 114–117.
Brown, K.E., Hibbs, J.R., Gallinella, G., Anderson, S.M., Lehman, E.D., McCarthy, P.,
Young, N.S., 1994. Resistance to parvovirus B19 infection due to lack of virus
receptor (erythrocyte P antigen). New Engl. J. Med. 330, 1192–1196.
Bon̈sch, C., Kempf, C., Ros, C., 2008. Interaction of parvovirus B19 with human
erythrocytes alters virus structure and cell membrane integrity. J. Virol. 82,
11784–11791.
Bon̈sch, C., Zuercher, C., Lieby, P., Kempf, C., Ros, C., 2010. The globoside receptor
triggers structural changes in the B19 virus capsid that facilitate virus inter-
nalization. J. Virol. 84, 11737–11746.
Cho, N.-J., Frank, C.W., Kasemo, B., Hoök̈, F., 2010. Quartz crystal microbalance with
dissipation monitoring of supported lipid bilayers on various substrates. Nat.
Protoc. 5, 1096–1106.
Clausen, H., Holmes, E., Hakomori, S., 1986. Novel blood group H glycolipid antigens
exclusively expressed in blood group A and AB erythrocytes (type 3 chain H).
I. Isolation and chemical characterization. J. Biol. Chem. 261, 1380–1387.
Cooling, L., Koerner, T., Naides, S., 1995. Multiple glycosphingolipids determine the
tissue tropism of parvovirus B19. J Infect. Dis. 172, 1198–1205.
Cooper, M.A., 2004. Advances in membrane receptor screening and analysis. J. Mol.
Recognit. 17, 286–315.
Dam, T.K., Brewer, C.F., 2010. Lectins as pattern recognition molecules: the effects of
epitope density in innate immunity. Glycobiology 20, 270–279.
Eierhoff, T., Stechmann, B., Rom̈er, W., 2012. Pathogen and toxin entry – how
pathogens and toxins induce and harness endocytotic mechanisms, in: Ceresa,
B. (Ed.), Molecular Regulation of Endocytosis.
Erb, E.M., Chen, X., Allen, S., Roberts, C.J., Tendler, S.J., Davies, M.C., Forsén, S., 2000.
Characterization of the surfaces generated by liposome binding to the modiﬁed
dextran matrix of a surface plasmon resonance sensor chip. Anal. Biochem. 280,
29–35.
Evans, S.V., Roger MacKenzie, C., 1999. Characterization of protein-glycolipid
recognition at the membrane bilayer. J. Mol. Recognit. 12, 155–168.
Ewers, H., Helenius, A., 2011. Lipid-mediated endocytosis. Cold Spring Harb.
Perspect. Biol. 3, a004721.
Ewers, H., Romer, W., Smith, A.E., Bacia, K., Dmitrieff, S., Chai, W., Mancini, R.,
Kartenbeck, J., Chambon, V., Berland, L., Oppenheim, A., Schwarzmann, G., Feizi,
T., Schwille, P., Sens, P., Helenius, A., Johannes, L., 2010. GM1 structure
determines SV40-induced membrane invagination and infection. Nat. Cell Biol.
12, 11–12.
Florea, A.V., Ionescu, D.N., Melhem, M.F., 2007. Parvovirus B19 infection in the
immunocompromised host. Arch. Pathol. Lab. Med. 131, 799–804.
Gallinella, G., 2013. Parvovirus B19 achievements and challenges. ISRN Virol. 2013,
1–33.
Hansson, G.C., Karlsson, K.A., Larson, G., Stromberg, N., Thurin, J., Orvell, C., Norrby,
E., 1984. A novel approach to the study of glycolipid receptors for viruses.
Binding of Sendai virus to thin-layer chromatograms. FEBS Lett. 170, 15–18.
Karlsson, K., Larson, G., 1981. Molecular characterization of cell surface antigens of
fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human Le
(abþ) secretor. J. Biol. Chem. 256, 3512–3524.
Kaufmann, B., Baxa, U., Chipman, P.R., Rossmann, M.G., Modrow, S., Seckler, R.,
2005. Parvovirus B19 does not bind to membrane-associated globoside in vitro.
Virology 332, 189–198.
Koppisetty, C.A., Nasir, W., Strino, F., Rydell, G.E., Larson, G., Nyholm, P.G., 2010.
Computational studies on the interaction of ABO-active saccharides with the
norovirus VA387 capsid protein can explain experimental binding data. J.
Comput. Aided Mol. Des. 24, 423–431.
Leisi, R., Ruprecht, N., Kempf, C., Ros, C., 2013. Parvovirus B19 uptake is a highly
selective process controlled by VP1u, a novel determinant of viral tropism. J.
Virol. 87, 13161–13167.
W. Nasir et al. / Virology 456-457 (2014) 364–369368
Lingwood, C.A., 1996. Aglycone modulation of glycolipid receptor function. Glyco-
conj. J. 13, 495–503.
Lingwood, C.A., 2011. Glycosphingolipid functions. Cold Spring Harb. Perspect. Biol.
3, 1–26.
Mammen, M., Choi, S.-K., Whitesides, G.M., 2010. Polyvalent interactions in
biological systems: implications for design and use of multivalent ligands and
inhibitors. Angew. Chem. Int. Ed. Engl. 30, 2755–2794.
Munakata, Y., Saito-Ito, T., Kumura-Ishii, K., Huang, J., Kodera, T., Ishii, T., Hirabaya-
shi, Y., Koyanagi, Y., Sasaki, T., 2005. Ku80 autoantigen as a cellular coreceptor
for human parvovirus B19 infection. Blood 106, 3449–3456.
Nilsson, J., Rydell, G.E., Le Pendu, J., Larson, G., 2009a. Norwalk virus-like particles
bind speciﬁcally to A, H and difucosylated Lewis but not to B histo-blood group
active glycosphingolipids. Glycoconj. J 26, 1171–1180.
Nilsson, J., Rüetschi, U., Halim, A., Hesse, C., Carlsohn, E., Brinkmalm, G., Larson, G.,
2009b. Enrichment of glycopeptides for glycan structure and attachment site
identiﬁcation. Nat. Methods 6, 809–811.
Nyholm, P.G., Pascher, I., 1993. Orientation of the saccharide chains of glycolipids at
the membrane surface: conformational analysis of the glucose-ceramide and
the glucose-glyceride linkages using molecular mechanics (MM3). Biochemis-
try 32, 1225–1234.
Romer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., Aly, M.R.,
Fraisier, V., Florent, J.C., Perrais, D., Lamaze, C., Raposo, G., Steinem, C., Sens, P.,
Bassereau, P., Johannes, L., 2007. Shiga toxin induces tubular membrane
invaginations for its uptake into cells. Nature 450, 670–675.
Rydell, G.E., Dahlin, A.B., Hook, F., Larson, G., 2009. QCM-D studies of human
norovirus VLPs binding to glycosphingolipids in supported lipid bilayers reveal
strain-speciﬁc characteristics. Glycobiology 19, 1176–1184.
Rydell, G.E., Svensson, L., Larson, G., Johannes, L., Rom̈er, W., 2013. Human GII.4
norovirus VLP induces membrane invaginations on giant unilamellar vesicles
containing secretor gene dependent α1,2-fucosylated glycosphingolipids. Bio-
chim. Biophys. Acta – Biomembr. 1828, 1840–1845.
Sens, P., Johannes, L., Bassereau, P., 2008. Biophysical approaches to protein-induced
membrane deformations in trafﬁcking. Curr. Opin. Cell Biol. 20, 476–482.
Servant-Delmas, A., Lefrère, J.-J., Morinet, F., Pillet, S., 2010. Advances in human B19
erythrovirus biology. J. Virol. 84, 9658–9665.
Servey, J.T., Reamy, B.V., Hodge, J., 2007. Clinical presentations of parvovirus B19
infection. Am. Fam. Physician 75, 373–376.
Svensson, L., Hult, A.K., Stamps, R., Ångstrom̈, J., Teneberg, S., Storry, J.R., Jørgensen,
R., Rydberg, L., Henry, S.M., Olsson, M.L., 2013. Forssman expression on human
erythrocytes: biochemical and genetic evidence of a new histo-blood group
system. Blood 121, 1459–1468.
Weigel-Kelley, K.A., Yoder, M.C., Srivastava, A., 2003. Alpha5beta1 integrin as a
cellular coreceptor for human parvovirus B19: requirement of functional
activation of beta1 integrin for viral entry. Blood 102, 3927–3933.
Yaegashi, N., Niinuma, T., Chisaka, H., Watanabe, T., Uehara, S., Okamura, K., Moffatt,
S., Sugamura, K., Yajima, A., 1998. The incidence of, and factors leading to,
parvovirus B19-related hydrops fetalis following maternal infection; report of
10 cases and meta-analysis. J. Infect. 37, 28–35.
Yamamoto, M., Cid, E., Yamamoto, F., 2012. Molecular genetic basis of the human
Forssman glycolipid antigen negativity. Sci. Rep. 2, 975.
Yang, Z., Bergstrom̈, J., Karlsson, K.A., 1994. Glycoproteins with Gal alpha 4Gal are
absent from human erythrocyte membranes, indicating that glycolipids are the
sole carriers of blood group P activities. J. Biol. Chem. 269, 14620–14624.
W. Nasir et al. / Virology 456-457 (2014) 364–369 369
